Purpose: This study investigated the risks of development and surgical complications of meconium obstruction (MO) in very low birth weight (VLBW) infants. Methods: We performed a retrospective medical record review of VLBW infants admitted to the neonatal intensive care unit of Haeundae Paik hospital and diag nosed with MO of prematurity (MOP) between March 2010 and August 2013. Results: Of 267 VLBW infants admitted to the neonatal intensive care unit, 28 were diagnosed with MOP. Perinatal factors including maternal pregnancyinduced hyper tension and small for gestational age were associated with MOP development (P<0.05). Over twothirds of VLBW infants with MOP were successfully treated with a gas trografin enema. The remaining eight VLBW infants required surgery. Although small for gestational age was more frequent in the medical treatment group, specific risk factors associated with MOP development did not affect the need for surgical inter vention. Conclusion: MOP is common in VLBW infants, as most VLBW infants have risk factors for MOP. Identifying risk factors permits early diagnosis and initiation of appropriate medical treatment, reducing the necessity for surgery. However, the presence of specific risk factors does not increase risk of surgical complications.
INTRODUCTION
Meconium plug syndrome (MPS) was first described by Clatworthy et al. 1) in 1956, as "intestinal obstruction due to the inability of the colon to rid itself of the meconium residue of 9 months of fetal life. " Since then, many types of meconiumrelated obstructions have been reported. Although, the concept and diagnostic criteria of each type of disease are still not definitive, meconium obstruction (MO) of prematurity (MOP) is accepted as a distinct clinical condition. The etiology of MOP is thought to be a com bination of highly viscous meconium and poor bowel motility of premature infants 2, 3) . Increased survival of extremely premature infants has resulted in an increased incidence of MOP 4, 5) .
MOP is usually benign but, if left untreated, longstanding bowel obstruction may lead to complications of necrosis and perforation, resulting in increased morbidity and mortality. Al though there is no definitive treatment protocol, cases diag nosed early respond well to conservative treatment. Therefore, identifying risk factors associated with MOP may allow early detection and appropriate timely intervention to reduce surgical complications.
This retrospective study was performed to determine the risk factors associated with MO development and the effect of these risk factors on surgical complications in very low birth weight (VLBW) infants.
MATERIAL AND METHODS
Patients
We reviewed the medical records of VLBW infants admitted to the neonatal intensive care unit of Haeundae Paik Hospital at
Inje University between March 2010 and August 2013. VLBW infants with a diagnosis of "meconium obstruction" were eligi ble for inclusion in this study. Infants who improved with simple conservative treatment with warm saline or glycerine enema were excluded. VLBW infants with spontaneous bowel perfora tion with no history of delayed meconium passage or inspissated meconium at laparotomy were excluded. VLBW infants with necrotizing enterocolitis (NEC) were also excluded.
Maternal and obstetric history was collected. Perinatal history and neonatal clinical data on diagnosis, treatment, clinical course, radiological features and outcome were also collected.
Diagnosis of MOP
The clinical features of MOP are a distended abdomen, bilious gastric residue, and delayed meconium passage in prematurity.
However, delayed meconium passage is common in preterm infants. Therefore, infants with isolated delayed meconium passage without "significant ileus" were excluded from the study. 
Management protocol
MOP was suspected when a newborn had difficulty with me conium passage and abdominal distension. Without evidence of NEC through radiological workups, rectal stimulation was per formed, and warm saline or a diluted glycerin enema was pro vided as firstline therapy. If this treatment was not effective, a bedside ultrasonographyguided gastrografin enema was per formed by a pediatric radiologist. In one patient, we administer ed 10% Nacetylcysteine via an orogastric tube. We perform ed surgical exploration in the remaining infants who had pro gressed to bowel perforation, persistent feeding intolerance with no response to the aforementioned medical therapies, or sus pected to have a mechanical cause of obstruction. Enteral feed ing was initiated as soon as possible after relieving MO. Human milk or formula milk for prematurity initially provided at 10 cc/ kg/day every three hours. The total feeding volume was in creased in 1020 cc/kg/day increments according to each pa tient's tolerance. 
Statistical analysis

RESULTS
During the study period, 267 VLBW infants were admitted and 28 (10.5%) were diagnosed with MOP.
Comparison of clinical characteristics and risk factors between the controls and the study group
The clinical characteristics of VLBW infants with MO and con trols are shown in 
Analysis of risk factors for MOP development
Almost 90% (n=25) of VLBW infants with MO had one or more identifiable perinatal risk factors. Maternal pregnancyinduced hypertension (PIH) and small for gestational age (SGA) were strongly associated with MOP development (P<0.05, Table 2 ).
Clinical characteristics and risk factors of VLBW infants with MO
Among 28 VLBW infants with MO, 20 were successfully treated with gastrografin enema. The remaining eight VLBW infants re quired surgical intervention. Gestational age and birth weight were not significantly different between the medical and surgical treatment groups. SGA was more frequent in the medical treat ment group than in the surgical treatment group. None of the specific risk factors associated with MOP development indicated a high risk of surgical complications (Table 3) .
VLBW infants successfully treated with gastrografin enema reached full enteral feeding significantly earlier than those requi ring surgery (P<0.05). There were no differences in other clini cal conditions, including respiratory distress syndrome, persis tent patent ductus arteriosus, bronchopulmonary dys plasia, intraven tricular hemorrhage and TPNassociated chole stasis between the medical and surgical treatment groups (some data not shown).
Treatment
1) Medical treatment group
The initial symptom of abdominal distension was observed in all of patients (symptom presentation mean, 2.5±0.8 days). In our study, most VLBW infants presented with symptoms within the first 4872 hours after birth. Although half the patients passed first meconium within 48 hours after birth, it was a small amount.
All VLBW infants received warm saline or half of a gly cerin enema prior to the gastrografin enema. When there was no evidence of NEC, they were treated with an ultrasonographyguided gastro grafin enema at 47 days after birth. Most VLBW infants showed improvement with one or two gastrografin enemas. Only four infants required repeated more than three enemas. There were no documented complications associated with gastrografin enema and patients could start enteral feeding at a mean of 6.7 days after birth.
2) Surgical treatment group
Characteristics of the surgical treatment group are shown in Table 4 . Eight VLBW infants were treated surgically in this study.
Ileostomy after evacuation of the lodged meconium plug by lavage through a small enterotomy was performed. The leading cause of exploration in five VLBW infants was definite free air observed on a simple radiograph (cases 1, 2, 3, 7, and 8). nical or functional obstruction is common in VLBW infants 4, 6) and often results in delayed initiation of enteral feeding and longer duration of TPN 7) . The main dilemma in MOP diagnosis is distinguishing it from simple delayed meconium passage of premature infants, leading to large differences in the reported incidences of MOP 8) . Though the exact incidence has not been established, it is clear that there has recently been a distinct in crease in the incidence of MO in VLBW infants 9) . In this present study, approximately 10% of VLBW infants were diag nosed and treated with MOP. This high incidence has great implications for healthcare professionals.
Numerous reports have described the risk factors of MOP 1012)
.
Kubota et al. stressed that functional hypomotility rather than mechanical obstruction of thick meconium causes MOP 13) . In MO, a micro or smallsized colon can be seen with a contrast enema. In cases of filling defects, their location is not identical to transition zone between dilated and collapsed bowel loops.
Initially, bowel hypomotility results in meconium stasis, leading to excessive water reabsorption. This makes meconium stickier and meconium plugs are formed. Therefore, the effect of meco nium does not appear to directly cause obstruction. Wellknown risk factors of MOP are maternal hypertension, PIH, oligohy dramnios, and chronic placenta abruption. These factors result in perinatal intestinal hypoperfusion, which in turn results in dysmotility of the gastrointestinal tract 14, 15) . Maternal diabetes might lead to fetal hypoglycemia with increased glucagon levels and decreased fetal bowel motility 16) . Additionally, magnesium sulfate administration to preeclamptic women or women in preterm labor is associated with functional bowel obstruction 13) .
In our study, most patients had at least one or more risk factors, with maternal PIH and SGA were strongly associated with MOP development. Previous reports have indicated that delays in initiating a gastrografin enema leads to lower success rates, and lower chances to avoiding surgical intervention 3, 17, 18) . Identifying risk factors associated with MOP may lead to early detection and initiation of appropriate, timely management.
Gastrografin enemas were first described as a therapeutic approach to relieve meconium ileus in 1969 19) . This treatment is thought to be an effective, safe, and repetitive therapeutic me thod for infants with MO 3) . Multiple reports have shown success rates of 5080% for gastrografin enemas in MPS used to avoid surgical intervention 3, 11, 18) . In this study, gastrografin enemas were effective in over 70% of MO patients. Ideally, it is recom mended that passing of the contrast agent through the dilated proximal bowel be confirmed by visualization using a radio opaque agent under fluoroscopic control. However, in clinically unstable premature infants, bedside ultrasonographyguided gastrografin enemas are safe and sufficient to diagnose and treat MO 20, 21) . Surgical intervention is mandatory in patients with bowel perforation and considered for those with worsening clinical condition and showing progression of abdominal disten sion 22) . This study has some limitations. As this study was conducted retrospectively, the standard treatment protocol for MOP was not uniformly applied in all patients. Additionally, the number of enrolled patients was small, limiting the statistical power.
However, this study has some important clinical implications. . Previous reports have suggested that
Hirschsprung's disease may cause meconium plugs 24, 25) . Although we excluded two VLBW infants in this study, these infants were initially treated as having MOP before a final diagnosis of con genital megacolon.
We report a group of 28 VLBW infants diagnosed and treated for MOP. Over twothirds of these infants were successfully treat ed with conservative treatment. Early intervention with a gastro grafin enema prevented surgical complications. As most infants had one or more risk factors, the identification of risk factors associated with MOP would allow clinicians to suspect and initiate proper therapeutic management. However, we did not find any significant associations between specific risk factors and the need for surgical intervention.
